1 - 25 of 258 results for author:"Croce C.M." in Literature citations
Results Customize
› Repeat search in UniProtKB (138)
| MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Romano G., Acunzo M., Garofalo M., Di Leva G., Cascione L., Zanca C., Bolon B., Condorelli G., Croce C.M. Proc. Natl. Acad. Sci. U.S.A. 109:16570-16575(2012) · Mapped (13) |
| Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene. Colamaio M., Cali G., Sarnataro D., Borbone E., Pallante P., Decaussin-Petrucci M., Nitsch L., Croce C.M., Battista S., Fusco A. J. Clin. Endocrinol. Metab. 97:E2168-78(2012) · Mapped (3) |
| MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Fabbri M., Paone A., Calore F., Galli R., Gaudio E., Santhanam R., Lovat F., Fadda P., Mao C., Nuovo G.J. et al. Proc. Natl. Acad. Sci. U.S.A. 109:E2110-6(2012) · Mapped (5) |
| Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice. Kriss C.L., Pinilla-Ibarz J.A., Mailloux A.W., Powers J.J., Tang C.H., Kang C.W., Zanesi N., Epling-Burnette P.K., Sotomayor E.M., Croce C.M. et al. Blood 120:1027-1038(2012) · Mapped (13) |
| Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia. Ranganathan P., Yu X., Na C., Santhanam R., Shacham S., Kauffman M., Walker A., Klisovic R., Blum W., Caligiuri M. et al. Blood 120:1765-1773(2012) · Mapped (4) |
| Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1. D'Angelo D., Palmieri D., Mussnich P., Roche M., Wierinckx A., Raverot G., Fedele M., Croce C.M., Trouillas J., Fusco A. J. Clin. Endocrinol. Metab. 97:E1128-38(2012) · Mapped (2) |
| POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation. Pero R., Palmieri D., Angrisano T., Valentino T., Federico A., Franco R., Lembo F., Klein-Szanto A.J., Del Vecchio L., Montanaro D. et al. J. Biol. Chem. 287:18308-18317(2012) · Mapped (13) |
| MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Suh S.S., Yoo J.Y., Nuovo G.J., Jeon Y.J., Kim S., Lee T.J., Kim T., Bakacs A., Alder H., Kaur B. et al. Proc. Natl. Acad. Sci. U.S.A. 109:5316-5321(2012) · Mapped (32) |
| miR-155 regulates IFN-gamma production in natural killer cells. Trotta R., Chen L., Ciarlariello D., Josyula S., Mao C., Costinean S., Yu L., Butchar J.P., Tridandapani S., Croce C.M. et al. Blood 119:3478-3485(2012) · Mapped (12) |
| Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL). Palamarchuk A., Yan P.S., Zanesi N., Wang L., Rodrigues B., Murphy M., Balatti V., Bottoni A., Nazaryan N., Alder H. et al. Proc. Natl. Acad. Sci. U.S.A. 109:2555-2560(2012) · Mapped (6) |
| In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. Fornari F., Milazzo M., Chieco P., Negrini M., Marasco E., Capranico G., Mantovani V., Marinello J., Sabbioni S., Callegari E. et al. J. Pathol. 227:275-285(2012) · Mapped (39) |
| EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Garofalo M., Romano G., Di Leva G., Nuovo G., Jeon Y.J., Ngankeu A., Sun J., Lovat F., Alder H., Condorelli G. et al. Nat. Med. 18:74-82(2012) · Mapped (41) |
| NOTCH1 mutations in CLL associated with trisomy 12. Balatti V., Bottoni A., Palamarchuk A., Alder H., Rassenti L.Z., Kipps T.J., Pekarsky Y., Croce C.M. Blood 119:329-331(2012) · Mapped (2) |
| Inflammation regulates microRNA expression in cooperation with p53 and nitric oxide. Mathe E., Nguyen G.H., Funamizu N., He P., Moake M., Croce C.M., Hussain S.P. Int. J. Cancer 131:760-765(2012) · Mapped (13) |
| AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia. Motiwala T., Zanesi N., Datta J., Roy S., Kutay H., Checovich A.M., Kaou M., Zhong Y., Johnson A.J., Lucas D.M. et al. Blood 118:6132-6140(2011) · Mapped (9) |
| miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPmu. Quintavalle C., Garofalo M., Zanca C., Romano G., Iaboni M., del Basso De Caro M., Martinez-Montero J.C., Incoronato M., Nuovo G., Croce C.M. et al. Oncogene 31:858-868(2012) · Mapped (7) |
| miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Acunzo M., Visone R., Romano G., Veronese A., Lovat F., Palmieri D., Bottoni A., Garofalo M., Gasparini P., Condorelli G. et al. Oncogene 31:634-642(2012) · Mapped (22) |
| A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Zhang Y., Xie R.L., Croce C.M., Stein J.L., Lian J.B., van Wijnen A.J., Stein G.S. Proc. Natl. Acad. Sci. U.S.A. 108:9863-9868(2011) · Mapped (11) |
| Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation. Orlovsky K., Kalinkovich A., Rozovskaia T., Shezen E., Itkin T., Alder H., Ozer H.G., Carramusa L., Avigdor A., Volinia S. et al. Proc. Natl. Acad. Sci. U.S.A. 108:7956-7961(2011) · Mapped (21) |
| p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. Kim T., Veronese A., Pichiorri F., Lee T.J., Jeon Y.J., Volinia S., Pineau P., Marchio A., Palatini J., Suh S.S. et al. J. Exp. Med. 208:875-883(2011) · Mapped (39) |
| Wwox inactivation enhances mammary tumorigenesis. Abdeen S.K., Salah Z., Maly B., Smith Y., Tufail R., Abu-Odeh M., Zanesi N., Croce C.M., Nawaz Z., Aqeilan R.I. Oncogene 30:3900-3906(2011) · Mapped (1) |
| Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. Fabbri M., Bottoni A., Shimizu M., Spizzo R., Nicoloso M.S., Rossi S., Barbarotto E., Cimmino A., Adair B., Wojcik S.E. et al. JAMA 305:59-67(2011) · Mapped (34) |
| Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Braconi C., Valeri N., Kogure T., Gasparini P., Huang N., Nuovo G.J., Terracciano L., Croce C.M., Patel T. Proc. Natl. Acad. Sci. U.S.A. 108:786-791(2011) · Mapped (5) |
| Effect of zinc supplementation on N-nitrosomethylbenzylamine-induced forestomach tumor development and progression in tumor suppressor-deficient mouse strains. Sun J., Liu J., Pan X., Quimby D., Zanesi N., Druck T., Pfeifer G.P., Croce C.M., Fong L.Y., Huebner K. Carcinogenesis 32:351-358(2011) · Mapped (14) |
| MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Valeri N., Gasparini P., Braconi C., Paone A., Lovat F., Fabbri M., Sumani K.M., Alder H., Amadori D., Patel T. et al. Proc. Natl. Acad. Sci. U.S.A. 107:21098-21103(2010) · Mapped (12) |